Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Conditions: Multiple Myeloma; Cytokine Release Syndrome; Refractory Multiple Myeloma; Immune Effector Cell Associated Neurotoxicity Syndrome Interventions: Drug: Siltuximab Sponsors: Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials